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Interaction of FGF, Ihh/Pthlh, and BMP Signaling
Integrates Chondrocyte Proliferation
and Hypertrophic Differentiation
parallel, cells from the perichondrium flanking the hyper-
trophic chondrocytes differentiate into bone-producing
osteoblasts, forming the periosteum (Erlebacher et al.,
1995; Hinchcliffe and Johnson, 1980). Pre- and postnatal
longitudinal growth of the skeletal elements depends
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on the prolongation of chondrocyte proliferation andIhnestrasse 73
hypertrophic differentiation. As hypertrophic chondro-14195 Berlin
cytes are constantly replaced by bone, proliferation andGermany
hypertrophic differentiation have to be tightly controlled2 Department of Pathology
to ensure proper bone development.The University of Texas Health Science Center at
Signaling by fibroblast growth factor (FGF) receptorsSan Antonio
plays a critical role in controlling chondrocyte differenti-San Antonio, Texas 78284
ation. This is exemplified by three inherited human3 Department of Molecular Biology and
dwarfism syndromes, hypochondroplasia, achondro-Pharmacology
plasia, and thanatophoric dysplasia, which are causedWashington University School of Medicine
by missense mutations in the FGF receptor 3 gene660 South Euclid Avenue
(Fgfr3; Bellus et al., 1995; Rousseau et al., 1994; ShiangSt. Louis, Missouri 63110
et al., 1994; Tavormina et al., 1995). These mutations
lead to different levels of receptor activation, which cor-
relates well with the severity of the human phenotypes
(Naski et al., 1996). Several mouse models mimicking the
Summary human achondroplasia phenotype have been created by
expressing mutated forms of Fgfr3 in the developing
Mutations in fibroblast growth factor (FGF) receptor 3 cartilage anlagen (Fgfr3ach mice; Chen et al., 1999;
lead to the human dwarfism syndrome achondropla- Iwata et al., 2000, 2001; Naski et al., 1998; Segev et al.,
sia. Using a limb culture system, we have analyzed 2000). These mice display a severe shortening of the
the role of FGF signaling and its interaction with the appendicular skeletal elements due to reduced regions
Ihh/Pthlh and BMP pathways in regulating chondro- of proliferating and hypertrophic chondrocytes. In con-
cyte differentiation. In contrast to previous sugges- trast, mice carrying a targeted deletion of Fgfr3 are char-
tions, we demonstrate that FGF signaling accelerates acterized by increased regions of proliferating and hy-
both the onset and the pace of hypertrophic differenti- pertrophic chondrocytes (Colvin et al., 1996; Deng et
ation. We furthermore found that FGF and BMP signal- al., 1996). These studies have led to the conclusion that
ing act in an antagonistic relationship regulating chon- FGF signaling is a negative regulator of chondrocyte
drocyte proliferation, Ihh expression, and the process proliferation and differentiation. The expression of Fgfr3
of hypertrophic differentiation. Importantly, BMP sig- in proliferating and early hypertrophic chondrocytes
naling rescues the reduced domains of proliferating correlates well with the bone phenotype in Fgfr3 mutant
and hypertrophic chondrocytes in a mouse model for mice.
achondroplasia. We propose a model in which the bal- Several lines of evidence have demonstrated that two
ance of BMP and FGF signaling adjusts the pace of other signaling factors, parathyroid hormone-like pep-
the differentiation process to the proliferation rate. tide (Pthlh; formerly PTHrP), expressed in periarticular
chondrocytes (Lee et al., 1995), and Indian hedgehog (Ihh),
expressed in prehypertrophic chondrocytes (Bitgood andIntroduction
McMahon, 1995), interact in a negative feedback loop to
regulate the onset of hypertrophic differentiation (Vort-During embryonic development, endochondral ossifica-
kamp et al., 1996). First, overexpression of Ihh (Vortkamption starts with the aggregation of mesenchymal cells,
et al., 1996) or Pthlh (Weir et al., 1996) or constitutivewhich differentiate into chondrocytes forming cartilage
activation of the Pthlh receptor (Pthr; formerly PTH/elements. In parallel, cells peripheral to the condensa-
PTHrP receptor; Schipani et al., 1997) results in a de-
tion differentiate into a fibroblastic cell layer, the peri-
layed onset of hypertrophic differentiation of chondro-
chondrium, surrounding the cartilage elements. Initially,
cytes. Second, overexpression of Ihh leads to increased
all chondrocytes proliferate. At later stages starting from expression of Pthlh (Vortkamp et al., 1996), whereas Ihh
the center of the cartilage element, chondrocytes un- knockout mice do not express Pthlh (St-Jacques et al.,
dergo a multistep program, differentiating into prehyper- 1999). Third, activation of Ihh signaling inhibits hypertro-
trophic, hypertrophic, and finally terminal hypertrophic phic differentiation of chondrocytes in wild-type mice
chondrocytes. The region of terminally differentiated but not in Pthlh or Pthr mutant mice (Lanske et al., 1996;
chondrocytes is subsequently invaded by blood vessels Vortkamp et al., 1996). These results place Ihh upstream
followed by osteoclasts and osteoblasts, which start to of Pthlh and lead to a model in which Ihh serves as a
replace the cartilage with bone and bone marrow. In measure for the number of chondrocytes undergoing
hypertrophic differentiation, whereas the downstream
factor Pthlh prevents chondrocytes from initiating the4 Correspondence: vortkamp@molgen.mpg.de
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differentiation process. The level of Ihh and Pthlh signal- of FGF signaling during chondrocyte development and
its interactions with other signaling pathways, we haveing thus regulates the distance from the joint region
at which hypertrophic differentiation takes place and used a limb explant culture system (Minina et al., 2001).
Treatment of limbs from E14.5 or E16.5 mouse embryosindirectly determines the domain of proliferating chon-
drocytes (Chung et al., 2001; Vortkamp et al., 1996). In with FGF2 resulted in severe shortening of the skeletal
elements compared to untreated control limbs (Figureaddition, targeted deletion of Ihh in mice revealed that
Ihh directly regulates chondrocyte proliferation and is 1A). To analyze the effect of FGF2 treatment at the mo-
lecular level, we hybridized sections of these limbs withnecessary for the ossification of endochondral bones
(Karp et al., 2000; St-Jacques et al., 1999). Ihh and type X collagen (ColX), markers of prehypertro-
phic and hypertrophic cells, respectively. Limbs treatedBone morphogenetic proteins (BMP), a subgroup of
the transforming growth factor  family (TGF-), are a with FGF2 displayed smaller domains of Ihh and ColX
expression than limbs from untreated cultures (Figuresthird group of secreted signaling factors regulating bone
formation (reviewed in Massague, 2000; Massague et 1B, 1C, 1N, and 1O). In addition, BrdU labeling revealed
a reduced rate of chondrocyte proliferation after FGF2al., 2000). Several in vitro and in vivo studies have shown
that BMP signaling induces chondrocyte proliferation treatment (Figures 2I and 2J). Therefore, the molecular
changes induced by FGF2 strongly resemble theleading to enlarged skeletal elements (Zou et al., 1997),
whereas a loss of BMP signaling by overexpressing the Fgfr3ach phenotype.
In addition to the reduced domains of Ihh and ColXBMP antagonist Noggin (Capdevila and Johnson, 1998;
Pathi et al., 1999) or dominant-negative forms of the expression, we found an increased distance between
the two ColX-expressing domains in E14.5 limb ex-BMP receptors results in reduced bone growth (Zou and
Niswander, 1996). In previous studies, we have demon- plants. Hybridization with osteopontin (secreted phos-
phoprotein 1; Spp1) and matrix metalloproteinase 13strated that Ihh and BMP signals interact at several
stages to regulate chondrocyte development. We found (MMP13), markers for terminally differentiated hypertro-
phic chondrocytes and osteoblasts, revealed that atthat Ihh signaling induces the expression of several
Bmp genes and that both signals act in parallel to regu- both stages, E14.5 and E16.5, FGF2 treatment results
in an increased expression of Spp1 and MMP13 (Figureslate chondrocyte proliferation. Conversely, BMPs in-
duce the expression of Ihh in cells that are released 1D and 1P and data not shown). To differentiate between
terminal hypertrophic cells and osteoblasts, we hybrid-from the range of Pthlh signaling, thus indirectly regulat-
ing the onset of hypertrophic differentiation. In addition, ized some of the FGF2-treated limbs with osteocalcin
(Oc), which is exclusively expressed in osteoblasts. Wethe process of hypertrophic differentiation is negatively
regulated by BMP signaling independently of the Ihh/ found strong expression of Oc in the periosteum flanking
the hypertrophic regions, but no expression could bePthlh system (Minina et al., 2001).
In this study, we have investigated the epistatic rela- detected in the cartilage core in cells expressing Spp1
and MMP13 (data not shown). FGF2 treatment thereforetionship between the three signaling pathways. We
found that FGF signaling regulates chondrocyte prolifer- seems to accelerate chondrocyte differentiation into ter-
minal hypertrophic cells. Interestingly, MMP13 wasation, the level of Ihh expression, and the rate of terminal
hypertrophic differentiation. One important finding to upregulated at postnatal day 7 (P7) in Fgfr3ach mice,
carrying one of the human achondroplasia mutationscome out of this analysis is that FGF signaling actually
acts to promote hypertrophic differentiation instead of (G380R) under the Collagen-II (ColII) promoter (Fgfr3ach
(G380R) mice; Naski et al., 1998). No significant upregu-delaying it as previously suggested. The apparent de-
crease in the amount of hypertrophic chondrocytes is lation could be detected at E14.5 or E16.5 (Figures 4H
and 4K and data not shown; n  2 for each stage).thus a secondary consequence of the accelerated differ-
entiation process in combination with the reduced prolif-
eration rate. This new interpretation has important impli- FGF Signaling Acts Upstream of Ihh in Regulating
cations for understanding the etiology of dwarfism the Onset of Hypertrophic Differentiation
syndromes. As activation of FGF signaling in the limb The Ihh/Pthlh signaling system has been demonstrated
culture system resembles a loss of BMP signals, we to control the onset of hypertrophic differentiation of
have analyzed the interaction of FGF and BMP signaling. chondrocytes, demarcated by the distance between the
We found that both pathways act in antagonistic rather Ihh expression domain and the joint region (Vortkamp
than epistatic relationships regulating chondrocyte pro- et al., 1996). As described above, FGF2 treatment leads
liferation, Ihh expression, and the process of hypertro- to reduced expression of Ihh. In addition, the distance
phic differentiation. Accordingly, we have shown that between the Ihh expression domain and the periarticular
BMP treatment rescues the reduced domains of prolifer- region is reduced after FGF2 treatment, indicating an
ating and hypertrophic chondrocytes in a mouse model advanced onset of hypertrophic differentiation (Figures
for achondroplasia. 1B and 1N; Table 1). To address the question of whether
FGF signals directly regulate the onset of hypertrophic
differentiation in parallel to the Ihh/Pthlh system orResults
whether the phenotype is a secondary consequence of
the reduced expression of Ihh after FGF2 treatment,FGF Signaling Regulates Chondrocyte
Proliferation and Differentiation we attempted to rescue the FGF2-induced effect by
cotreatment with Pthlh. Compared to limbs treated withActivated FGF signaling in Fgfr3ach mice results in re-
duced zones of proliferating and hypertrophic chondro- FGF2 double treatment with FGF2 and Pthlh resulted
in an increased distance between the Ihh expressioncytes (Naski et al., 1998). To further investigate the role
FGF, Ihh/Pthlh, and BMP Signaling in Chondrogenesis
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Figure 1. Interaction of FGF Signaling with the Ihh/Pthlh System
(A) Forelimbs of E14.5 mouse embryos were cultured for 2 days with (FGF2-2d) or without (control-2d) FGF2 and compared to uncultured
limbs (0d). Rulers demarcate relative units, and the black lines indicate the size of the FGF2-treated explant.
(B–Y) Forelimbs of E14.5 mouse embryos were cultured for 2 days in control medium (B–E) or treated with Pthlh (F–I), FGF2 and Pthlh (J–M),
FGF2 (N–Q), FGF2 and cyclopamine (R–U), or cyclopamine (V–Y). Serial sections were hybridized with antisense riboprobes for Ihh (B, F, J,
N, R, and V), ColX (C, G, K, O, S, and W), and Spp1 (D, H, L, P, T, and X). Bmp7 (E, I, M, Q, U, and Y) was hybridized to sections of parallel
cultures. Treatment with FGF2 results in an advanced onset of hypertrophic differentiation demarcated by the reduced distance between the
Ihh expression domain and the joint region (B and N) and a reduced Bmp7 expression domain (E and Q). In addition, FGF2 reduces the
expression of Ihh and ColX and increases the expression of Spp1 (B–D and N–P). Pthlh delays the onset of hypertrophic differentiation and
increases the Bmp7 expression domain but does not upregulate Spp1 expression (B–I). Cotreatment with FGF2 and Pthlh results in a delay
of the onset of hypertrophic differentiation compared to treatment with FGF2 (J, M, N, and Q) and in an increased expression of Spp1 compared
to treatment with Pthlh (H and L). Blocking of Ihh signaling by cyclopamine advances the onset of hypertrophic differentiation but does not
regulate Spp1 expression (V–Y). Cotreatment with cyclopamine and FGF2 does not accelerate the onset of hypertrophic differentiation
compared to treatment with cyclopamine alone but results in upregulation of Spp1 expression (R–Y). Double-sided arrows demarcate the
distance between the Ihh expression domain and the joint region (red) or the size of the Bmp7 expression domain (black) after FGF2 treatment.
Red arrows point to upregulated Spp1 expression. In all panels, ulna is up and radius is down. cycl, cyclopamine.
domain and the periarticular region, indicating a delay which is expressed at a low level in the distal population
of proliferating chondrocyte. Strong expression is foundin chondrocyte differentiation. However, due to the re-
duced proliferation rate (see below), this distance does in the central region of proliferating chondrocytes flank-
ing the Ihh expression domain. FGF treatment resultsnot reach that of Pthlh-treated explants (Figures 1B, 1F,
1J, and 1N; Table 1). To further support these results, in a reduced size of the Bmp7 expression domain com-
pared to untreated explants (Figures 1E and 1Q). Thiswe have analyzed the expression of Bmp7 (n 2, each),
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phenotype, we treated limbs of mice overexpressing the
chicken Ihh gene under the ColII promoter (ColII/Ihh
embryos; Long et al., 2001) with FGF2. As in wild-type
limbs, we found reduced expression of the endogenous
Ihh message in ColII/Ihh mice after FGF2 treatment (Fig-
ures 2E and 2F). Corresponding to the reduced expres-
sion of the endogenous Ihh gene, slight reduction of
Pthlh expression was found in limb explants of wild-
type and ColII/Ihh embryos (Figures 2A–2D). However,
FGF2 treatment did not result in significantly reduced
Pthlh expression in ColII/Ihh embryos (Figures 2C and
2D) nor in a decreased distance between the Ihh expres-
sion domain and the periarticular region, indicating that
FGF signaling acts upstream of Ihh (compare Figures
2C and 2E with 2D and 2F).
As a third experiment, we tested whether FGF2 could
further advance the onset of hypertrophic differentiation
in limbs where the Ihh signal was blocked. As we have
demonstrated before, cyclopamine effectively blocks
Ihh signaling, resulting in an upregulation of Ihh expres-
sion and an advanced onset of hypertrophic differentia-
tion (Figures 1B, 1C, 1V, and 1W; Table 1; Minina et al.,
2001). Double treatment with cyclopamine and FGF2
did not further accelerate the onset of hypertrophic dif-
ferentiation compared to treatment with cyclopamine
alone (Figures 1B, 1N, 1R, and 1V; Table 1). Correspond-
ing to earlier results indicating that Ihh signaling upregu-
lates the expression of Bmp7 (Minina et al., 2001), treat-
ment with cyclopamine blocks the expression of Bmp7
in an FGF-independent way (Figures 1U and 1Y). Taken
together, these experiments strongly suggest that FGF
signaling acts upstream of the Ihh/Pthlh system in regu-
lating the onset of hypertrophic differentiation.
FGF Signaling Regulates Chondrocyte
Proliferation Independently of IhhFigure 2. FGF Signaling Acts Upstream of Ihh in Regulating the
Onset of Hypertrophic Differentiation but Independently in Regulat- Limb explants treated with FGF2 display a reduced rate
ing Terminal Hypertrophic Differentiation and Chondrocyte Prolifer- of chondrocyte proliferation (Figures 2I and 2J), whereas
ation Ihh has been shown to upregulate chondrocyte prolifer-
Forelimbs of E16.5 wild-type mice (A, B, I, and J) and ColII/Ihh ation (Long et al., 2001). Similar to the onset of hypertro-
embryos (C–H and K and L) were cultured for 2 days in control phic differentiation, Ihh might thus mediate the effect ofmedium (A, C, E, G, I, and K) or treated with FGF2 (B, D, F, H, J,
FGF signaling on chondrocyte proliferation. To test thisand L). Serial sections were hybridized with antisense riboprobes
hypothesis, we treated limb explants of ColII/Ihh em-for Pthlh (A–D) and Ihh (E and F). Spp1 (G and H) was hybridized to
limbs from parallel cultures. Proliferating cells were labeled with bryos with FGF2 and analyzed the proliferation rate by
BrdU and detected by antibody staining (I–L). The endogenous ex- BrdU labeling. We found a reduced rate of chondrocyte
pression of Ihh is reduced in ColII/Ihh mice by FGF2 treatment (E proliferation compared to untreated cultures (Figures
and F). However, FGF2 treatment does not result in significantly 2K and 2L), indicating that FGF signaling negatively reg-reduced expression of Pthlh in wild-type or mutant limbs (A–D). In
ulates chondrocyte proliferation independently of Ihh.addition, FGF2 treatment does not advance the onset of hypertro-
phic differentiation demarcated by the distance between the Pthlh
and Ihh expression domains (compare [C and E] with [D and F]). In FGF Signaling Regulates Terminal Hypertrophic
contrast, FGF2 treatment accelerates terminal hypertrophic differ- Differentiation Independently
entiation independently of Ihh (G and H) and reduces chondrocyte of the Ihh/Pthlh System
proliferation both in wild-type (I and J) and ColII/Ihh embryos (K
In addition to regulating the onset of hypertrophic differ-and L). Black arrows indicate the Pthlh expression domain. (A)–(H)
entiation, we found that FGF signaling induces the differ-display the proximal end of the humerus and (I)–(L) show the distal
entiation of terminal hypertrophic cells expressing Spp1ends of ulna (up) and radius (down).
(Figures 1D and 1P). In previous experiments, we did
not detect a role for Ihh in regulating the process of
hypertrophic differentiation itself (Minina et al., 2001).phenotype can be rescued by cotreatment with Pthlh
(Figure 1M), which on its own results in an increased To confirm that FGF signaling acts independently of Ihh
during this process, we cotreated limbs with FGF2 anddomain of Bmp7-expressing chondrocytes (Figure 1I).
Taken together, Pthlh acts downstream of FGF signaling cyclopamine. As expected, cyclopamine treatment in-
creased the region of ColX-expressing hypertrophicin regulating the onset of hypertrophic differentiation.
To test whether Ihh itself can rescue the FGF2-induced chondrocytes but had no effect on the differentiation of
FGF, Ihh/Pthlh, and BMP Signaling in Chondrogenesis
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Table 1. Onset of Hypertrophic Differentiation
Treatment Age N Length (%) SD P Value
F/control E14.5 9 83.15 5.21 0.001a
F/control E16.5 7 90.60 4.24 0.004a
FP/F E14.5 5 126.24 12.07 0.011a
FP/P E14.5 5 76.95 7.19 0.012a
P/control E14.5 6 133.14 15.25 0.004a
FC/F E14.5 4 85.82 10.29 0.086a,c
C/FC E14.5 5 88.01 13.45 0.149a,c
C/control E14.5 5 72.94 5.59 0.003a
contr/B E14.5 7 88.42 6.76 0.007a
F100B500/B E14.5 5 87.77 7.21 0.054a
F250B500/B E14.5 5 81.50 5.44 0.002a
F500B500/B E14.5 4 71.45 5.93 0.005a
F250B250/F E14.5 5 119.87 9.74 0.011a
F250B500/F E14.5 8 135.97 13.53 0.001a
F250B1000/F E14.5 5 145.11 34.76 0.055a
ach/wt E16.5 5 91.88 6.84 0.040b
ach and B/ach E16.5 6 114.14 6.09 0.004a
wt and B/wt E16.5 5 116.91 7.45 0.009a
a Paired, two-sided Student’s t test.
b Unpaired, two-sided Student’s t test.
c No significant difference, indicating a similar onset of hypertrophic differentiation.
B, BMP2; C, cyclopamine; F, FGF2; P, Pthlh; ach, Fgfr3ach(G380R) mice; wt, wild-type mice.
terminal hypertrophic cells expressing Spp1 (Figures FGF2 and BMP2. Double-treated limbs revealed an in-
creased rate of chondrocyte proliferation compared to1C, 1D, 1W, and 1X). In contrast, after double treatment
FGF2-treated limbs and a reduced proliferation ratewith cyclopamine and FGF2, the region of ColX-express-
compared to BMP2 treatment (Figures 3A, 3D, 3G, anding cells became smaller and Spp1 was highly expressed
3J). Similarly, cotreatment with BMP2 enhanced the re-(Figures 1O, 1P, 1S, 1T, 1W, and 1X), demonstrating that
duced domain of Ihh expression after FGF2 treatment.FGF signaling induces terminal hypertrophic differentia-
However, Ihh expression was still reduced compared totion independently of Ihh.
BMP2 treatment alone (Figures 3B, 3E, 3H, and 3K).This result was supported by explants cotreated with
Correspondingly, the distance between the Ihh expres-FGF2 and Pthlh. As described earlier, FGF2 induces an
sion domain and the joint region increased when com-advanced onset of hypertrophic differentiation, which
paring BMP2 treatment to cotreatment with FGF2 andis delayed by cotreatment with Pthlh. Nevertheless, in
BMP2, or to FGF2 alone (Figures 3B, 3E, 3H, and 3K;limbs double treated with Pthlh and FGF2, we found an
Table 1). Finally, the FGF2-induced expression of Spp1upregulation of Spp1 expression (Figures 1D, 1L, and
was inhibited by cotreatment with BMP2 but remained1P). In addition, the Ihh and ColX expression domains
higher than after BMP2 treatment alone (Figures 3C, 3F,were severely reduced compared to limbs treated with
3I, and 3L). Interestingly, double-treated cultures did noteither factor (Figures 1F, 1G, 1J, 1K, 1N, and 1O). Such an
resemble the BMP2 or FGF2 phenotype, as would beeffect would be expected if hypertrophic differentiation
expected if one pathway acted downstream of the otherwas delayed by Pthlh and, simultaneously, the hypertro-
in an epistatic relationship. We therefore speculated thatphic chondrocytes that were present at the start of the
FGF and BMP signals act in parallel, antagonisticculture underwent accelerated hypertrophic differentia-
pathways.tion. Similarly, treatment of limbs overexpressing Ihh
To further support this idea, we cotreated limbs withwith FGF2 resulted in an upregulation of Spp1 expres-
the optimized concentration of BMP2 used in previoussion (Figures 2G and 2H), supporting the idea that FGF
experiments and varying concentrations of FGF2. Wesignaling regulates terminal hypertrophic differentiation
found that the expression domain of Ihh in these culturesindependently of the Ihh/Pthlh system.
decreased with increasing concentrations of FGF2 (Fig-
ures 3B, 3K, 3N, 3Q, and 3T). Correspondingly, the dis-
FGF Signaling Is Antagonized by BMP Signals tance between the articular region and the Ihh-express-
In previous studies, we have shown that BMP signaling ing chondrocytes was reduced in relation to the FGF2
upregulates the expression of Ihh, increases the rate of concentration (Figures 3B, 3K, 3N, 3Q, and 3T; Table 1).
chondrocyte proliferation, and delays the differentiation Similarly, increasing concentrations of FGF2 resulted in
of terminal hypertrophic chondrocytes. In contrast, an increase in Spp1 expression (Figures 3C, 3L, 3O, 3R,
blocking BMP signals by Noggin treatment results in a and 3U) and a reduced proliferation rate (Figures 3A,
phenotype very similar to that of FGF2 treatment (Minina 3J, 3M, 3P, and 3S). In contrast, in cultures treated with
et al., 2001). Thus, BMP and FGF signals seem to have a constant FGF2 concentration and increasing amounts
opposite functions during chondrocyte development. of BMP2, the level of Ihh expression, its distance from
To investigate the epistatic relationship between the the joint region, the rate of chondrocyte proliferation,
and the expression of Spp1 were determined by thetwo signaling systems, we cotreated limb explants with
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Figure 3. BMP and FGF Signaling Have An-
tagonistic Effects on Chondrocyte Devel-
opment
Forelimbs of E14.5 embryos were cultured for
4 days in control medium (A–C) or in medium
supplemented with FGF2 (D–F), FGF2 and
BMP2 (G–I), BMP2 (J–L), and with 500 ng/ml
BMP2 and FGF2 at different concentrations:
100 ng/ml (M–O), 250 ng/ml (P–R), or 500 ng/
ml (S–U). Proliferating cells were labeled with
BrdU and detected by antibody staining (A,
D, G, J, M, P, and S). Serial sections were
hybridized with antisense riboprobes for Ihh
(B, E, H, K, N, Q, and T) and Spp1 (C, F, I, L,
O, R, and U).
(A–L) Limbs cotreated with BMP2 and FGF2
display an intermediate rate of chondrocyte
proliferation and intermediate domains of Ihh
and Spp1 expression compared to limbs
treated with either BMP2 or FGF2. In addition,
the distance between the Ihh expression do-
main and the joint region has an intermediate
length compared with one after either BMP2
or FGF2 treatment.
(M–U) In cultures with a defined concentra-
tion of BMP2, chondrocyte proliferation and
the size of the domain of Ihh and Spp1 ex-
pression depend on the concentration of
FGF2. Double-sided arrows demarcate the
size of the Ihh expression domain (red) or the
distance between the joint region and the Ihh
expression domain after treatment with 250
ng/ml FGF2 (black) compared to this distance
in each experiment (blue line).
amount of BMP2 (Table 1 and data not shown). Taken differentiated into Bmp7-expressing chondrocytes nor-
mally found in the medial proliferating region. Similarlytogether, these experiments strongly support an antago-
nistic function of FGF and BMP signaling in regulating in Fgfr3ach(G380R) mice, Bmp7 expression is upregu-
lated at E14.5 and E16.5 (Figures 4G and 4J and datachondrocyte development.
not shown; n 2 for each stage). Conversely, treatment
of limb explants with BMP2 resulted in a slight upregula-BMPs and FGFs Regulate the Expression of Genes
tion of Fgf18 in the perichondral region surrounding thefrom the Opposing Family
cartilage elements (Figures 4C and 4F). Thus, BMP andTo address whether BMP and FGF signals regulate the
FGF signals positively regulate the production of growthexpression of other members of the FGF and BMP fam-
factors from the opposing pathways.ily, we have treated limbs with FGF2 and analyzed the
expression of Bmp4 and Bmp7. We found that Bmp4
is slightly upregulated in the proliferating and terminal BMP Signaling Rescues the Achondroplasia
Phenotype in a Mouse Modelhypertrophic chondrocytes (Figures 4A and 4D). Inter-
estingly, in addition to an upregulation of Bmp7, the As BMP signaling can antagonize the FGF2-induced
effects on chondrocyte development, we asked whetherdomain of Bmp7-expressing cells was markedly shifted
toward the joint region (Figures 4B and 4E). Thus, the BMP2 treatment would rescue the reduced rate of chon-
drocyte proliferation and the reduced size of the hyper-cells of the distal region of proliferating chondrocytes
that normally express only low amounts of Bmp7 have trophic region in Fgfr3ach(G380R) mice. Limb explants
FGF, Ihh/Pthlh, and BMP Signaling in Chondrogenesis
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Figure 4. BMP and FGF Signaling Positively
Regulate Gene Expression of the Opposite
Pathways
(A–F) Forelimbs of E14.5 wild-type embryos
were cultured for 2 days in control medium
(A–C) or in medium supplemented with FGF2
(D and E) or BMP2 (F). Serial sections were
hybridized with antisense riboprobes for
Bmp4 (A and D), Bmp7 (B and E), and Fgf18
(C and F). Sections of forelimbs of E14.5 (G
and J) and P7 (H, I, K, and L) Fgfr3ach(G380R)
mice were hybridized with antisense ribo-
probes for Bmp7 (G and J), MMP13 (H and
K), and Ihh (I and L). Treatment with FGF2
results in slight upregulation of Bmp4 expres-
sion in the perichondrium and in terminal hy-
pertrophic chondrocytes (A and D) and strong
upregulation of Bmp7 expression in prolifer-
ating chondrocytes (B and E). Similarly, Bmp7
is upregulated in E14.5 Fgfr3ach(G380R)
mice (J) compared to wild-type littermates
(G). Treatment with BMP2 increases Fgf18
expression in the perichondrium (C and F). At
P7, Ihh expression in Fgfr3ach(G380R) mice
and the distance from the Ihh expression do-
main to the joint region are reduced (I and L).
In addition, MMP13 is upregulated in mutant
mice compared to wild-type (H and K). Dou-
ble-sided black arrows demarcate the dis-
tance between the Ihh expression domain
and the joint region of Fgfr3ach(G380R) mice.
In (A–G) and (J), ulna is up and radius is down,
and (H), (I), (K), and (L) display sections
through the radius. ach, Fgfr3ach(G380R)
mice; wt, wild-type.
of E16.5 transgenic mice were cultured for 2 days. Simi- indicating an advanced onset of hypertrophic differenti-
ation (Figures 4I and 4L, uncultured; Figures 5B and 5H,lar to the results of Naski et al. (1998), we found that limb
explants of Fgfr3ach(G380R) mice displayed a reduced after culture; Table 1). Treatment with BMP2 resulted in
increased expression of Ihh and an enlarged distancerate of chondrocyte proliferation (Figures 5A and 5G)
and reduced domains of Ihh and ColX expression com- between the Ihh expression domain and the joint region
(Figures 5B, 5E, 5H, and 5K). In addition, the ColX ex-pared to limbs of wild-type littermates (Figures 5B, 5C,
5H, and 5I). In addition, the distance between the Ihh pression domain was enlarged after BMP2 treatment
(Figures 5C, 5F, 5I, and 5L). Finally, BMP2 treatment ledexpression domain and the joint region was shortened,
Figure 5. BMP Signaling Rescues the Achon-
droplasia Phenotype in a Mouse Model
Forelimbs of E16.5 wild-type (A–F) and
Fgfr3ach(G380R) (G–L) embryos were cultured
for 2 days in control medium (A–C and G–I) or
in medium supplemented with BMP2 (D–F and
J–L). Serial sections were hybridized with
antisense riboprobes for Ihh (B, E, H, and K)
or ColX (C, F, I, and L). Proliferating cells were
labeled with BrdU and detected by antibody
staining (A, D, G, and J). As in wild-type limbs,
BMP2 treatment increases the expression of
Ihh (B, E, H, and K) and ColX (C, F, I, and
L) in hypertrophic cells of Fgfr3ach(G380R)
mice. In addition, treatment with BMP2 leads
to a delay in the onset of hypertrophic differ-
entiation, as can been seen from the in-
creased distance between Ihh-expressing
cells and the joint region (H and K). Further-
more, BMP2 treatment increases the reduced
rate of chondrocyte proliferation in Fgfr3ach(G380R) mice (G and J). Black arrows demarcate the distance between the Ihh expression domain
and the joint region in untreated Fgfr3ach(G380R) mice. Red double-sided arrows demarcate the Ihh expression domain, compared to the




to an increase of chondrocyte proliferation compared pace of chondrocyte differentiation in phase with the
to untreated limbs of Fgfr3ach(G380R) mice (Figures development of the embryo. The Ihh/Pthlh system regu-
5G and 5J). These experiments demonstrate that BMP lates the distance from the joint region at which cells
signaling can improve the cartilage phenotype resulting switch from proliferating into differentiating chondro-
from activated FGF signaling in a mouse model for cytes. If FGF signals would only downregulate chondro-
achondroplasia, supporting the idea of an antagonistic cyte proliferation, it would take a longer developmental
relationship between these signaling systems. time to establish the Pthlh-determined distance for hy-
pertrophic differentiation. Instead, by simultaneously
Discussion downregulating proliferation and the Ihh/Pthlh feedback
loop, FGF signaling adjusts the initiation of hypertrophic
FGF Signaling Accelerates differentiation to the proliferation rate and allows chon-
Hypertrophic Differentiation drocytes to differentiate closer to the joint region. Simi-
In this study, we have used an organ culture system for larly, the region of hypertrophic cells must be regulated
embryonic limb explants to investigate the interaction by specific, not yet identified signaling systems. By ac-
of FGF signaling with that of the Ihh/Pthlh and BMP celerating terminal hypertrophic differentiation, FGF sig-
signaling systems. First, we demonstrated that treat- naling might fulfill a similar function, namely adapting the
ment of limb explants with FGF2 mimics the phenotype differentiation process to the reduced proliferation rate.
of activated FGFR3 signaling in Fgfr3ach(G380R) mice
(Naski et al., 1998) by reducing the rate of chondrocyte FGF Signaling and Chondrocyte Proliferation
proliferation and the domain of Ihh- and ColX-express- Different laboratories have investigated the negative
ing hypertrophic chondrocytes. In addition, our studies role of FGF signaling on chondrocyte proliferation and
revealed that the distance between the domain of Ihh found that FGF signaling activates STAT1 and possibly
expression and the joint region is reduced by FGF sig- other members of the STAT family of transcription fac-
nals. As this distance demarcates the onset of hypertro- tors. Activation of STAT1 in turn leads to the upregulat-
phic differentiation, the effect of FGF2 can be interpreted ing of the cell cycle inhibitor p21WAF1/CIP1, thereby inhib-
as an advanced onset of chondrocyte differentiation. iting chondrocyte proliferation (Li et al., 1999; Sahni et
Another signaling system regulating the onset of hyper- al., 1999, 2001).
trophic differentiation is the Ihh/Pthlh signaling system. Ihh signaling has been shown to positively regulate
Cotreatment of limb cultures with Pthlh and FGF2 (our chondrocyte proliferation (Long et al., 2001). Here we
study) or treatment of metatarsal from achondroplasia show that in contrast to the regulation of the onset of
or Fgfr3/ mice with Pthlh (Chen et al., 2001) results in a hypertrophic differentiation, both signaling pathways
delay of chondrocyte differentiation. Similarly, activation act independently of each other in regulating chondro-
of FGF signaling in limb explants of mice overexpressing cyte proliferation. This result is supported by recent
Ihh cannot overcome the delay in hypertrophic differen- experiments showing that activation of Ihh signaling re-
tiation. These experiments strongly support the hypoth- sults in an upregulation of Cyclin D1, a positive regulator
esis that FGF signaling acts upstream of the Ihh/Pthlh of the cell cycle (Long et al., 2001). Although more exper-
system in regulating the onset of hypertrophic differenti- iments will be necessary to reveal the interaction of the
ation. As activated FGF signaling in addition results in two signal pathways on the molecular level, they seem
reduced expression of Ihh in limb cultures and in Fgfr3ach to act on different regulators of the cell cycle.
mice, FGF signals seem to regulate the onset of hyper-
trophic differentiation by directly regulating Ihh expres-
Signaling through FGF Receptorssion. Interestingly, Bmp7 expression, which is normally
The expression of Fgfr3 in proliferating and early hyper-found in the medial proliferating zone, is shifted toward
trophic chondrocytes implicates a role for this receptorthe joint region by activated FGF signaling, indicating
in regulating chondrocyte proliferation and Ihh expres-advanced chondrocyte differentiation even in the pool
sion. In contrast, terminal hypertrophic differentiationof proliferating chondrocytes.
might be mainly regulated by Fgfr1 (Delezoide et al.,Surprisingly, treatment of limb explants with FGF2
1998), which is strongly expressed in hypertrophic chon-resulted in an increased region of Spp1-expressing ter-
drocytes. The ColII promoter, which is used to expressminal hypertrophic chondrocytes, indicating an acceler-
the activated Fgfr3 in the achondroplasia mouse model,ation of the process of hypertrophic differentiation. By
is only weakly expressed in hypertrophic chondrocytes.cotreatment experiments, we have shown that this ac-
Nevertheless, we have found an upregulation of Spp1celeration occurs independently of the Ihh/Pthlh system.
expression in these mice. Thus, low expression ofBased on our results, we reinterpret the role for FGF
Fgfr3ach(G380R) in hypertrophic chondrocytes seemssignaling in regulating chondrocyte development in the
to be sufficient to accelerate hypertrophic differentia-following model. Instead of delaying hypertrophic differ-
tion. Interestingly, this acceleration was found postna-entiation of chondrocytes, as has been suggested in
tally, indicating an increasing sensitivity of bone devel-previous studies, our experiments show that FGF signal-
opment to FGF signaling with age. As Fgfr3 is expresseding accelerates hypertrophic differentiation, both by in-
at a similarly low level in hypertrophic chondrocytes asducing the onset of hypertrophic differentiation and by
ColII, activation of signaling through FGFR3 is likely toaccelerating the differentiation process itself. In concert
accelerate terminal hypertrophic differentiation in achon-with the reduced rate of chondrocyte proliferation, this
droplasia patients. The age-dependent increasing sensi-acceleration leads to the decreased domains of hyper-
tivity to FGF signaling would thus add to the increasingtrophic chondrocytes seen in Fgfr3ach mice. By regulat-
ing both processes, FGF signaling seems to keep the severity of the achondroplasia phenotype with age.
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This is supported by the expression of at least some
members of the Bmp and Fgf family such as Bmp7 and
Fgf18, which are up- and not downregulated, as would
be expected in an epistatic relationship. Such an upreg-
ulation of antagonistically acting signals might serve
to compensate variations in gene expression or signal
transduction and thus stabilize proper chondrocyte dif-
ferentiation. The observed upregulation of Bmp4 is in
contrast to the results of Naski et al. (1998) and might
reflect an age-dependent difference. In contrast, Bmp7
is clearly upregulated after FGF2 treatment and in
Fgfr3ach(G380R) mice at embryonic stages.
As FGFs and BMPs signal through different types of
kinase receptors and intracellular mediators, it will be
Figure 6. Integration of FGF, BMP, and Ihh/Pthlh Signaling into a important to investigate at which point the pathways
Common Control Network
converge. Both signaling systems could, for example,
For details, see text. regulate the same promoters. Alternatively, both signal-
ing pathways could regulate distinct downstream genes,
which might then convey the antagonistic functions. A
A question not addressed in our study is which mem- third possibility is that both signaling systems interact
bers of the FGF family regulate the specific steps during cytoplasmically at the level of the signal transduction
chondrocyte differentiation in vivo. Fgf2, Fgf9, Fgf8, and cascade. BMPs signal through serine/threonine kinase
Fgf17 (see references in Liu et al., 2002) have been receptors that upon phosphorylation activate transcrip-
shown to be expressed in the developing cartilage anla- tion factors of the Smad family (Massague, 2000). FGFs
gen; however, inactivation of these Fgfs in mice does signal through tyrosine kinase receptors, which in turn
not result in skeletal dysmorphologies. Recently, mice can activate at least two intracellular pathways, the ex-
have been created carrying a targeted deletion of Fgf18 tracellular signal-regulated kinase (Erk) pathway and the
(Liu et al., 2002; Ohbayashi et al., 2002). Interestingly, phosphatidylinositol-3-OH kinase (PI[3] kinase) path-
these mice display an increased rate of chondrocyte way. Interestingly, Kretzschmar et al. have analyzed Erk-
proliferation and an elongated hypertrophic region simi- mediated signaling of the epidermal growth factor (EGF)
lar to Fgfr3/ mice, indicating that FGF18 signals and its interaction with BMP signals in cell cultures.
through FGFR3. In addition, reduced expression of Spp1 They found that activation of the Erk pathway can inhibit
and delayed bone formation has been found in these BMP-induced phosphorylation of Smad1, thus pre-
mice. Thus, FGF18 may also signal through other recep- venting transport of the Smad1-Smad4 complex into the
tors, for example FGFR1, to regulate terminal hypertro- nucleus (Kretzschmar et al., 1997). It will be interesting
phic differentiation and thus the ossification process. to investigate whether FGF and BMP signals interact in
comparable ways to regulate chondrocyte proliferation
and differentiation.FGF and BMP Signaling Act as Antagonists
during Cartilage Development
In previous studies, we have investigated the role of BMP Signaling and Achondroplasia
Achondroplasia, the most common form of inheritedBMP signaling and its interaction with the Ihh/Pthlh sys-
tem. We found that BMPs regulate chondrocyte prolifer- human dwarfism, results from an activation of FGF sig-
naling (Naski et al., 1996). In addition to their reducedation in parallel to Ihh. Furthermore, BMP signaling
upregulates the expression of Ihh in cells that are re- body size, achondroplasia patients often suffer from
severe pain as a result of bone and joint malformations.leased from the range of the Pthlh signal. Last but not
least, BMP signaling delays the differentiation of termi- No successful treatment for achondroplasia has been
found to date. In our study, we have started to unravelnal hypertrophic chondrocytes (Minina et al., 2001).
Thus, BMP and FGF signals seem to regulate the same the interaction of FGF signaling with that of the BMP
and Ihh/Pthlh signaling system. We demonstrate thatstages of chondrocyte development, mediating however
opposite effects. We have used double treatment with BMP signaling can rescue the achondroplasia pheno-
type on the molecular level by increasing the domainsBMP2 and FGF2 to analyze the epistatic relationship
between the two signaling systems. All three parameters of proliferating and hypertrophic chondrocytes. These
experiments demonstrate the importance of deci-tested—proliferation, Ihh expression, and terminal hyper-
trophic differentiation—showed an intermediate pheno- phering the precise integration of different signaling sys-
tems to understand the molecular origins of dwarfismtype relative to treatment with either FGF2 or BMP2,
alone. Furthermore, by varying the concentrations of the diseases. Such an understanding will be a prerequisite
in order to develop specific treatment strategies. Ihhtwo factors in cotreatment experiments, we found that
the balance of the concentrations was critical for the and Pthlh signaling, for example, can rescue the FGF-
induced advanced onset of hypertrophic differentiation.resulting phenotype. In contrast to an epistatic relation-
ship, where the downstream signal should determine However, in combination with elevated FGF signals,
treatment with either factor would further reduce thethe phenotype, our experiments strongly indicate that
FGF and BMP signals act in independent pathways hav- region of hypertrophic chondrocytes, thereby most
likely enhancing the bone phenotype. In contrast, BMPing antagonistic effects on chondrocyte development.
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by PCR of tail DNA as previously described (Naski et al., 1998; Longsignaling seems to act at very similar stages of chondro-
et al., 2001).cyte development, as does FGF signaling. Therefore,
manipulating the BMP signaling pathway would be a
Analysis of Limb Explants
more promising approach to improve the achondropla- Limb explants were fixed overnight in 4% paraformaldehyde at 4C
sia phenotype. Further in vitro and in vivo studies will, and embedded in paraffin. Serial sections of 5 m were processed
however, be necessary to understand the molecular for radioactive in situ hybridization using [P33]UTP-labeled antisense
riboprobes. Hybridization was carried out at 70C in 50% formamidemechanism of their interaction.
as previously described (Vortkamp et al., 1996). Sections were coun-
terstained with toluidine blue (Sigma). Probes for in situ hybridization
Interaction of FGF, BMP, and Ihh/Pthlh Signaling were as follows: rColII (Kohno et al., 1984), mColX (Jacenko et al.,
1993), mIhh (Bitgood and McMahon, 1995), mSpp1 (Kim et al., 1999),Based on the results of our study and previous investiga-
rPthlh (Karaplis et al., 1990), mBmp4 and mBmp7 (Bitgood andtions, we suggest the following model of how FGF sig-
McMahon, 1995), mFgf18 (Xu et al., 2000), and mMMP13 (Yamagiwanals interact with the Ihh/Pthlh and the BMP signaling
et al., 1999). For proliferation analysis, limb explants were labeledpathways to control chondrocyte development (Figure with 5-bromo-2-deoxyuridine (BrdU) and proliferating cells were de-
6). As previously described, Ihh, which is expressed in tected by antibody staining according to the manufacturer’s proce-
the prehypertrophic chondrocytes, induces the expres- dure (Minina et al., 2001).
sion of various Bmps in the flanking perichondrium/
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